Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
161.7 USD | -0.57% | -3.62% | +4.36% |
Apr. 30 | Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent | MT |
Apr. 29 | Health Care Up on Growth Optimism -- Health Care Roundup | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.36% | 286B | |
+33.25% | 699B | |
+26.06% | 571B | |
-3.55% | 364B | |
+18.16% | 326B | |
+15.32% | 236B | |
+5.49% | 198B | |
-9.78% | 194B | |
-3.69% | 149B | |
-5.59% | 154B |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- AbbVie Says Phase 3 Interim Data Support Long-Term Efficacy, Safety of Migraine Drug